Skip to main content
Signal8

Medical Care Technologies (OTC PINK:MDCE) Begins Advanced Internal Beta Testing of MDCE Melanoma Scan Imaging Platform

$MDCEPress releaseJun 12, 2026, 9:11 AM ETRead the release

Medical Care Technologies has begun internal beta testing of its MDCE Melanoma Scan imaging platform. The testing focuses on platform stability, workflow optimization, and image consistency as part of the software's development cycle.

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.